AJ

American Journal of Hematology

American Journal of Hematology is devoted to the coverage of blood diseases in humans and in animal models of human disease. It publishes research on non-malignant and malignant hematological diseases, including clinical and basic studies in leukemia, hemostasis and thrombosis, immunology, blood banking, and stem cell biology.

Looking to publish in American Journal of Hematology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Hematology
Impact Factor 9.9
Quartile Q1
Open Access Type Hybrid
ISSN 0361-8609
eISSN 1096-8652
Invitation Only No
Cost Range No page charges will be levied against authors or their institutions for publication in this journal. Open access is available as an option. Color figures may be published online free of charge, but there is a charge for publishing figures in color in print.

Submission Instructions

American Journal of Hematology accepts the following article types. Click on an article type to view submission instructions.

Research Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Research Articles require an unstructured abstract. Abstract must be 250 words or less. Abstract must be unstructured.
Manuscript Text should be limited to a maximum of 5,000 words. Manuscript must follow the format Introduction, Methods, Results, and Discussion. If artificial intelligence generated content tools were used, their use must be described transparently and in detail in the Methods or Acknowledgments section.
References Research Articles should contain no more than 100 references. References must be numbered consecutively in order of appearance, with in-text citations given as Arabic superscript numerals in consecutive order.
Figures & Tables Research Articles may contain a maximum of 7 figures and tables in total. Figures and tables must be uploaded as separate files, with tables submitted as separate Word files. Figure legends must be provided for each figure and placed at the end of the manuscript text file, and figures and tables must be numbered consecutively with Arabic numerals.
Reformat to American Journal of Hematology using Livewrite Premium

Critical Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. Abstract must be unstructured and 100 words or less. Abstract must be unstructured.
Manuscript Critical Reviews should normally comprise less than 6,000 words. Manuscript must contain the sections abstract, introduction, methods, results, and conclusions. If an artificial intelligence generated content tool was used to develop any portion of the manuscript, its use must be described transparently and in detail in the Methods or Acknowledgments section.
References Critical Reviews should use fewer than 150 references. References may be submitted in any style or format as long as the style is consistent throughout the manuscript. References may be submitted in any style or format as long as the style is consistent throughout the manuscript.
Figures & Tables Critical Reviews should contain no more than 6 figures or tables. Tables must be included in the main text file, and figures may be submitted as separate files. Figures and tables must be numbered consecutively with Arabic numerals, and a figure legend defining all abbreviations must be provided for each figure at the end of the manuscript text file.
Reformat to American Journal of Hematology using Livewrite Premium

Correspondence

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is not required for Correspondence.
Manuscript Correspondence must be no more than 1,500 words. The introduction must begin with “To the Editor:” and headers must not be included. If an artificial intelligence generated content tool was used, its use must be described transparently and in detail in the Methods or Acknowledgments section.
References Correspondence should contain no more than 20 references. References may be submitted in any style or format as long as the style is consistent throughout the manuscript. References may be submitted in any style or format as long as the style is consistent throughout the manuscript.
Figures & Tables Correspondence should contain no more than 3 tables and/or figures. Tables must be included in the main text file, and figures may be submitted separately. Figures and tables must be numbered consecutively with Arabic numerals, and each figure must have a legend placed at the end of the manuscript text file.
Reformat to American Journal of Hematology using Livewrite Premium

Recent Publications

Issue Information

-

10.1002/ajh.70454
View Publication

Targeting B‐Cell‐Activating Factor and Its Receptor in Immune Thrombocytopenia and Warm Autoimmune Hemolytic Anemia

Matthieu Mahévas, Nichola Cooper, Vickie McDonald, Karina Yazdanbakhsh, Wilma Barcellini

10.1002/ajh.70460
View Publication

HOPE Kids 2: Phase 3, Randomized Trial of Voxelotor in Children With SCD and Conditional Cerebral Blood Flow Velocities

Halima Bello‐Manga, Shehu Umar Abdullahi, Hoda Hassab, Biobele Brown, Videlis Nduba, Jessie Githanga, Adeseye Michael Akinsete, Amal El‐Beshlawy, Diana Hanna, Catherine Segbefia, Iheanyi Okpala, Azza Tantawy, Bernhards Ogutu, Venée N. Tubman, Vivian Paintsil, Yasser Wali, Mohammed Essa, Paul Telfer, Sandy Dixon, Anne Hickman, Jennifer F. Doss, Mark W. Davis, Jeremy Rupon, Fenella J. Kirkham, R. Clark Brown

10.1002/ajh.70457
View Publication

Cognitive Impairment, Depression and Cerebral Microbleeds in Immune Thrombocytopenia ( ITP )

Camelia Vladescu, Rozanna Meijboom, Alice C. J. Hart, Deena Paul, Christine Ademokun, Ariam Teklemichael, Bridget Chivers, Anastasia Gontsarova, Richard Szydlo, Adam D. Waldman, Nichola Cooper

10.1002/ajh.70462
View Publication

BiRD Regimen Followed by Anti‐ BCMA CAR ‐T Cell Immunotherapy as First‐Line Therapy for Newly Diagnosed Multiple Myeloma: A Prospective, Single‐Arm, Phase 2 Trial

Yue Zhou, Juan Chen, Qingya Cui, Haiping Dai, Zheng Li, Jia Yin, Wei Cui, Mengyun Li, Xuekai Li, Xin Zhang, Feiran Gong, Xiaming Zhu, Liqing Kang, Lei Yu, Depei Wu, Xiaowen Tang

10.1002/ajh.70485
View Publication

Frequently asked questions

How long does it take to publish?

Median submission to first decision is 4 days.

Reformat to American Journal of Hematology using Livewrite Premium

What are the publication costs?

No page charges will be levied against authors or their institutions for publication in this journal. Open access is available as an option.

Reformat to American Journal of Hematology using Livewrite Premium

Research Topics

Hemoglobinopathies and Related Disorders Acute Myeloid Leukemia Research Chronic Lymphocytic Leukemia Research Myeloproliferative Neoplasms: Diagnosis and Treatment Lymphoma Diagnosis and Treatment Platelet Disorders and Treatments Blood groups and transfusion Iron Metabolism and Disorders Chronic Myeloid Leukemia Treatments Acute Lymphoblastic Leukemia research Hematopoietic Stem Cell Transplantation Erythrocyte Function and Pathophysiology Multiple Myeloma Research and Treatments Eosinophilic Disorders and Syndromes Viral-associated cancers and disorders Blood disorders and treatments Blood Coagulation and Thrombosis Mechanisms Immunodeficiency and Autoimmune Disorders Complement system in diseases Immune Cell Function and Interaction Blood properties and coagulation Venous Thromboembolism Diagnosis and Management Hemophilia Treatment and Research Hematological disorders and diagnostics Neonatal Health and Biochemistry

Related Journals

JS
JOR Spine WILEY
JO
Journal of Biochemical and Molecular Toxicology WILEY
PA
Pediatric Anesthesia WILEY
JO
Journal of Oral Rehabilitation WILEY
BO
BJS Open WILEY
EE
European Eating Disorders Review WILEY